Skip to content
OpenCapital
Get started

Ironwood Pharmaceuticals IRWD Increase (decrease) in other current liabilities

Increase (decrease) in other current liabilities at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$21M+6,207%

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-—
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×—
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%—
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity0×-0.5×
Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's increase (decrease) in other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's increase (decrease) in other current liabilities?
Ironwood Pharmaceuticals (IRWD) reported increase (decrease) in other current liabilities of -$219K in Q1 2026.
How has Ironwood Pharmaceuticals's increase (decrease) in other current liabilities changed year-over-year?
Ironwood Pharmaceuticals's increase (decrease) in other current liabilities decreased by 217.1% year-over-year, from $187K to -$219K.
What is the long-term trend for Ironwood Pharmaceuticals's increase (decrease) in other current liabilities?
Over 3 years (2021 to 2025), Ironwood Pharmaceuticals's increase (decrease) in other current liabilities has grown at a 47.9% compound annual growth rate (CAGR), from -$1.27M to $4.11M.